Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary heart disease
|
1178 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.080 | 1.000 | 8 | 2001 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2002 | 2012 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2012 | 2019 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.040 | 1.000 | 4 | 2003 | 2015 | ||||
Coronary Arteriosclerosis
|
440 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 1.000 | 3 | 2001 | 2005 | ||||
Hyperhomocysteinemia
|
45 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.030 | 1.000 | 3 | 2002 | 2017 | ||||
Acute lymphocytic leukemia
|
222 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2012 | 2012 | ||||
Attention deficit hyperactivity disorder
|
420 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2017 | 2018 | ||||
Autistic Disorder
|
395 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2009 | 2016 | ||||
Bladder Neoplasm
|
281 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Carcinoma of bladder
|
309 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Carcinoma of lung
|
1204 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2005 | 2011 | ||||
Epilepsy
|
339 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Impaired cognition
|
348 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2007 | 2017 | ||||
Ischemic stroke
|
704 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2001 | 2007 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 1999 | 2004 | ||||
Malignant neoplasm of lung
|
1142 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2005 | 2011 | ||||
Malignant neoplasm of stomach
|
615 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Neoplasms
|
1644 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2003 | 2010 | ||||
Parkinson Disease
|
990 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2007 | 2011 | ||||
Primary malignant neoplasm of lung
|
981 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2005 | 2011 | ||||
Retinoblastoma
|
193 | 0.496 | 0.800 | 1 | 236885200 | missense variant | A/G | snv | 0.20 | 0.21 | 0.020 | 1.000 | 2 | 2010 | 2015 |